In short
The first drug, baricitinib, is a Janus kinase (JAK) inhibitor- a class of drugs used to treat autoimmune conditions, blood and bone marrow cancers, and rheumatoid arthritis. According to the WHO Guideline Development Group, it is strongly recommended for patients with severe or critical disease in combination with corticosteroids.
WHO Recommends Two New Drugs to Treat Patients with COVID-19 Top story
14 Jan 2022, 07:25 Comments 1078 Views Kampala, Uganda Health Updates
IP: 35.172.111.71. Referrer: . FirstClickFree: 0. Clicks by IP: ?. Clicks by cookie: ?.